Emmaus Life Sciences Inc (EMMA)
0.105
0.00 (0.00%)
USD |
OTCM |
May 09, 16:00
Emmaus Life Sciences Debt to Equity Ratio: -0.8928 for Sept. 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.8928 |
| June 30, 2023 | -0.9672 |
| March 31, 2023 | -0.9201 |
| December 31, 2022 | -0.8085 |
| September 30, 2022 | -0.8198 |
| June 30, 2022 | -0.9196 |
| March 31, 2022 | -1.129 |
| December 31, 2021 | -0.8581 |
| September 30, 2021 | -1.683 |
| June 30, 2021 | -2.495 |
| March 31, 2021 | -2.020 |
| December 31, 2020 | -2.788 |
| September 30, 2020 | -2.480 |
| June 30, 2020 | -1.151 |
| March 31, 2020 | -3.071 |
| December 31, 2019 | -1.317 |
| September 30, 2019 | -1.096 |
| June 30, 2019 | 0.162 |
| March 31, 2019 | 0.2996 |
| December 31, 2018 | 0.2756 |
| September 30, 2018 | 0.1462 |
| June 30, 2018 | 0.1857 |
| March 31, 2018 | 0.312 |
| December 31, 2017 | 0.2734 |
| September 30, 2017 | 0.0069 |
| Date | Value |
|---|---|
| June 30, 2017 | -0.0481 |
| March 31, 2017 | 0.1139 |
| December 31, 2016 | 0.0963 |
| September 30, 2016 | -0.0824 |
| June 30, 2016 | -0.6123 |
| March 31, 2016 | -0.5998 |
| December 31, 2015 | -0.5528 |
| September 30, 2015 | -0.5719 |
| June 30, 2015 | -0.5926 |
| March 31, 2015 | -0.61 |
| December 31, 2014 | -0.59 |
| September 30, 2014 | -0.8378 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | -0.0033 |
| June 30, 2013 | -0.5875 |
| March 31, 2013 | -0.6276 |
| December 31, 2012 | -0.683 |
| September 30, 2012 | -0.5654 |
| June 30, 2012 | -0.3819 |
| March 31, 2012 | -0.2768 |
| December 31, 2011 | -0.3733 |
| September 30, 2011 | -0.0005 |
| June 30, 2011 | -0.3189 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-3.071
Minimum
Mar 2020
0.162
Maximum
Jun 2019
-1.403
Average
-1.112
Median
Debt to Equity Ratio Benchmarks
| AIM ImmunoTech Inc | 0.00 |
| Perspective Therapeutics Inc | 0.0229 |
| Protalix BioTherapeutics Inc | 0.6033 |
| Electromed Inc | 0.00 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 47.45M |
| Total Liabilities (Quarterly) | 83.78M |
| Shareholders Equity (Quarterly) | -36.33M |
| Current Ratio | 0.152 |
| Net Debt Paydown Yield | -1.75% |